Ми більше, ніж просто дистриб’ютор





Meril logo

Meril is a global medical device company dedicated towards design and development of novel, clinically relevant, state-of-the-art and best-in-class devices to alleviate human suffering and improve the Quality of Life, spanning broad operational canvas from vascular interventional devices to orthopedics, in-vitro diagnostics and endo-surgery.



Meril-DES-Drug Eluting Stents

Drug Eluting Stent Biomime


Stent Architecture

  • Cobalt chromium (L605) platform with 65µm strut thickness.
  • Hybrid cell design comprising of an intelligent mix of open and close cells resulting in excellent radial strength with a high flexibility.
  • 0.29% foreshortening
  • Unique strut width variability that ensure a <3% recoil and 0.29% foreshortening
  • Special electro-polishing technique eliminates surface nickel oxides

Low injury Design – Morphology Mediated ExpansionTM

  • Conventional edge-flaring stent designs allow the stent to dog-bone during deployment.
  • This dog-boning coupled with balloon overhang may cause edge injury.
  • BioMime has struts with design variability which results in morphology mediated expansionTM, having a propensity to minimize stent edge injury.


Drug - Sirolimus

  • Sirolimus acts on the common final pathway of cell division cycle without exceptional risk of necrosis induction
  • Low drug loading of 1.25µgm/mm2 of Sirolimus
  • Drug elution time of 30 days.


More information >